MiCo BioMed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	4,066	9,354	5,678	23,811	20,855	9,605
Short-Term Investments	256.75	13,284	7,744	12,154	3,278	183.28
Trading Asset Securities	-	-	573.05	-	-	-
Cash & Short-Term Investments	4,323	22,638	13,995	35,965	24,133	9,788
Cash Growth	-21.40%	61.76%	-61.09%	49.03%	146.55%	-
Accounts Receivable	1,929	2,120	1,681	11,065	10,750	822.12
Other Receivables	147.1	190.43	59.8	127.74	20.65	62.59
Receivables	7,738	10,078	2,304	11,783	11,430	1,283
Inventory	8,778	11,248	17,684	18,751	19,518	4,870
Prepaid Expenses	362.01	468.01	490.64	951.46	764.88	189.73
Other Current Assets	914.82	2,956	2,058	2,230	1,466	551.96
Total Current Assets	22,115	47,387	36,531	69,681	57,311	16,682
Property, Plant & Equipment	5,843	5,606	10,401	16,058	11,671	6,368
Long-Term Investments	3,359	1,267	8,160	76.46	76.46	0.2
Goodwill	5,359	5,253	28.77	-	-	-
Other Intangible Assets	584.13	778.48	1,140	1,381	842.96	773.73
Long-Term Deferred Charges	-	-	-	0	13.45	94.79
Other Long-Term Assets	862.94	861.96	697.03	981.6	645.01	661.69
Total Assets	38,275	61,318	57,512	88,677	70,960	25,031
Accounts Payable	798.09	838.24	358.29	846.36	1,643	618.35
Accrued Expenses	501.63	649.75	231.82	278.72	261.2	304.66
Short-Term Debt	11,971	1,258	7,000	7,000	3,078	15,571
Current Portion of Long-Term Debt	-	6,601	9,546	-	0	-0
Current Portion of Leases	952.81	872.36	740.79	1,161	618.94	582.4
Other Current Liabilities	1,750	7,316	9,553	2,437	3,274	1,301
Total Current Liabilities	15,973	17,535	27,430	11,723	8,875	18,377
Long-Term Debt	-	2,579	3,376	7,968	65.72	261.02
Long-Term Leases	2,487	2,351	2,619	6,036	2,973	2,623
Long-Term Deferred Tax Liabilities	77.82	87.55	100.52	113.49	126.46	139.43
Other Long-Term Liabilities	145.97	279.49	4,327	7,365	535.6	524.92
Total Liabilities	20,821	24,989	39,872	36,444	15,017	24,030
Common Stock	21,784	21,784	9,154	9,148	9,076	6,487
Additional Paid-In Capital	146,592	146,592	113,582	111,284	104,034	45,598
Retained Earnings	-150,912	-131,730	-105,855	-68,225	-57,044	-51,082
Treasury Stock	-23.87	-23.87	-13.36	-19.55	-19.55	-19.55
Comprehensive Income & Other	-1,705	357.99	825.94	71.06	-84.41	36.85
Total Common Equity	15,736	36,981	17,693	52,259	55,961	1,021
Minority Interest	1,718	-651.96	-53.48	-25.29	-19.36	-20.33
Shareholders' Equity	17,454	36,329	17,639	52,234	55,942	1,000
Total Liabilities & Equity	38,275	61,318	57,512	88,677	70,960	25,031
Total Debt	15,411	13,660	23,282	22,164	6,736	19,037
Net Cash (Debt)	-11,088	8,977	-9,287	13,801	17,397	-9,249
Net Cash Growth	-	-	-	-20.67%	-	-
Net Cash Per Share	-270.83	362.78	-422.95	629.69	994.16	-649.94
Filing Date Shares Outstanding	43.56	43.56	21.96	21.95	21.77	14.23
Total Common Shares Outstanding	43.56	43.56	21.96	21.95	21.77	14.23
Working Capital	6,142	29,852	9,101	57,958	48,436	-1,695
Book Value Per Share	361.26	848.97	805.52	2380.94	2570.00	71.72
Tangible Book Value	9,793	30,949	16,525	50,878	55,118	246.98
Tangible Book Value Per Share	224.82	710.50	752.33	2318.02	2531.29	17.35
Land	-	-	1,169	1,169	1,151	-
Buildings	-	-	1,669	1,669	1,644	-
Machinery	8,843	8,322	8,320	8,075	6,880	4,622
Construction In Progress	382.88	184.24	267.4	526.82	294.86	7

Source: S&P Capital IQ. Standard template. Financial Sources.